End Stage Renal Disease Treatment Market
According to Intent Market Research, the End-Stage Renal Disease Treatment Market is expected to grow from USD 15.4 Billion in 2024-e at a CAGR of 8.2% to touch USD 26.8 Billion by 2030. The End-Stage Renal Disease Treatment Market is dominated by key players such as, DaVita Inc., Baxter International Inc., Medtronic PLC, Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, and B. Braun Melsungen AG.